3 Pharmaceutical Stocks That Are Too Cheap to Ignore

On average, healthcare stocks haven't kept up with the gains made by the rest of the market this year. While the S 500 index is up by more than 17% year to date, that sector's stocks are down by nearly 3%. That trend, though, created some great opportunities to get in on solid value stocks that are underpriced and offer solid dividends.

Viatris (NASDAQ: VTRS), (NYSE: GSK), and Organon (NYSE: OGN) are too inexpensive to pass up at this point. All three pharmaceutical stocks trade at under 7 times earnings and have forward price-to-earnings ratios of less than 10.

GSK PE Ratio data by YCharts.

Source Fool.com